Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Low-Priced Generic Drugs Most Likely to Have Shortages
THURSDAY, Dec. 27, 2018 (HealthDay News) — The lowest-priced generic drugs are more likely to experience shortages, according to a study published in the November issue of Value in Health.
Abstract/Full Text (subscription or payment may be required)
Universal Vaccination for MenB at College Entry Not Cost-Effective
THURSDAY, Dec. 27, 2018 (HealthDay News) — Universal vaccination against Neisseria meningitidis serogroup B (MenB) at college entry does not appear to be cost-effective, according to a study published online Dec. 17 in the American Journal of Preventive Medicine.
Initiative Can Cut Gender Gap in Medical School Faculty Salaries
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — An institutional gender equity initiative (GEI) can reduce gender-based salary gaps among medical school faculty, according to a study published online Dec. 21 in JAMA Network Open.
Updated Guidelines Developed for Diagnosing, Treating Influenza
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — The Infectious Diseases Society of America has updated their recommendations for the care of patients with suspected or diagnosed influenza; the clinical practice guidelines were published online Dec. 19 in Clinical Infectious Diseases.
Appalachia, Western States Have Highest Hep C Prevalence
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — States in the West and in Appalachia have a higher prevalence of hepatitis C virus (HCV) infection than other states, according to a study published online Dec. 21 in JAMA Network Open.
ACOG: Interpregnancy Period Should Maximize Women’s Health
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — Providers should maximize women’s health during the interpregnancy period, continuing care beyond the immediate postpartum period, according to a consensus report published online Dec. 20 in the American Journal of Obstetrics & Gynecology.
Abstract/Full Text (subscription or payment may be required)
Drug Use-Associated Infective Endocarditis Up 2007 to 2017
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — From 2007 to 2017 there was an increase in drug-use associated infective endocarditis (DUA-IE) hospitalizations and valve surgeries, according to a study published online Dec. 4 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required
Editorial (subscription or payment may be required)
HPV Ups Cervical Cancer Risk, Even With No Cellular Signs
Few Staff Receive Formal Training on CLABSI Surveillance for Home Infusion 
7.7 Million Deaths Associated With 33 Bacterial Pathogens in 2019 
U.S. Deaths From Infective Endocarditis Increasing in the Young 
Antiseptics Work Equally Well in Preventing Infection After Surgery for Open Fractures 
Geriatric Fracture Program Tied to Improved Outcomes 
Sublobar Resection Not Inferior to Lobar Resection for T1aN0 NSCLC 
Hospital Volume Affects Liver Surgery Outcomes 
Patients With Degenerative Meniscus Tears Do Not Benefit From Surgery 
